VCBeat Health Contact Us
Home Huahai Pharmaceutical's Subsidiary Receives FDA Orphan Drug Designation for HB0034 Injection

Huahai Pharmaceutical's Subsidiary Receives FDA Orphan Drug Designation for HB0034 Injection

Oct 17, 2023 15:50 CST Updated 15:50
Huahai Pharmaceutical

Medical and Health Product Provider

Huaota

Biological New Drug Developer

FDA

U.S. Food and Drug Administration

Huahai Pharmaceutical: Subsidiary's Product HB0034 Injection Receives U.S. FDA Orphan Drug Designation.